Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats. [electronic resource]
Producer: 20121218Description: 900-7 p. digitalISSN:- 1600-0455
- Administration, Rectal
- Animals
- Cell Survival
- Chitosan -- pharmacokinetics
- Colon -- cytology
- Contrast Media -- pharmacokinetics
- Feasibility Studies
- Gadolinium DTPA -- pharmacokinetics
- HeLa Cells
- Humans
- Image Enhancement -- methods
- Intestinal Absorption
- Intestinal Mucosa -- metabolism
- Magnetic Resonance Imaging
- Male
- Nanoparticles -- toxicity
- Random Allocation
- Rats
- Rats, Sprague-Dawley
- Reference Values
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.